These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32001614)

  • 1. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
    Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Keshavarzi S; Gao X; Braffett BH; Canty AJ; Herman WH; Orchard TJ; Dagogo-Jack S; Nathan DM; Lachin JM; Paterson AD;
    Diabetes Care; 2021 Jun; 44(6):1309-1316. PubMed ID: 33883194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC study.
    Bebu I; Braffett BH; Orchard TJ; Lorenzi GM; Nathan DM; Herman WH; Lachin JM
    Diabetes Res Clin Pract; 2021 Jan; 171():108591. PubMed ID: 33310124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Purnell JQ; Braffett BH; Zinman B; Gubitosi-Klug RA; Sivitz W; Bantle JP; Ziegler G; Cleary PA; Brunzell JD;
    Diabetes Care; 2017 Dec; 40(12):1756-1762. PubMed ID: 29138273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
    Miller RG; Costacou T; Orchard TJ
    Diabetes; 2019 Feb; 68(2):409-419. PubMed ID: 30409781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Cardiovascular Disease in Type 1 Diabetes.
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group
    Diabetes; 2016 May; 65(5):1370-9. PubMed ID: 26895792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM; Backlund JY; Bayless M; Bluemke DA; Cleary PA; Crandall J; Lachin JM; Lima JA; Miao C; Turkbey EB;
    Diabetes; 2013 Oct; 62(10):3561-9. PubMed ID: 23520132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR; Pober D; Galderisi A; Lv H; Yu L; Pereira AC; Doria A; Kosiborod M; Lipes MA
    Circulation; 2019 Feb; 139(6):730-743. PubMed ID: 30586738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Writing Group for the DCCT/EDIC Research Group
    Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group
    Diabetes Care; 2016 May; 39(5):686-93. PubMed ID: 26861924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC.
    Jaffa MA; Bebu I; Luttrell D; Braffett BH; Lachin JM; Hunt K; Lopes-Virella M; Luttrell L; Lyons TJ; Jaffa AA;
    Diabetes; 2020 Nov; 69(11):2440-2445. PubMed ID: 32826295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Soliman EZ; Backlund JC; Bebu I; Orchard TJ; Zinman B; Lachin JM;
    Diabetes Care; 2017 Jun; 40(6):793-799. PubMed ID: 28302651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
    Gubitosi-Klug R; Gao X; Pop-Busui R; de Boer IH; White N; Aiello LP; Miller R; Palmer J; Tamborlane W; Wallia A; Kosiborod M; Lachin JM; Bebu I;
    Diabetes Care; 2021 Jul; 44(7):1499-1505. PubMed ID: 33980605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.
    Braffett BH; Bebu I; El Ghormli L; Cowie CC; Sivitz WI; Pop-Busui R; Larkin ME; Gubitosi-Klug RA; Nathan DM; Lachin JM; Dagogo-Jack S;
    JAMA Netw Open; 2022 Sep; 5(9):e2230710. PubMed ID: 36074461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Cleary PA; Orchard TJ; Genuth S; Wong ND; Detrano R; Backlund JY; Zinman B; Jacobson A; Sun W; Lachin JM; Nathan DM;
    Diabetes; 2006 Dec; 55(12):3556-65. PubMed ID: 17130504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.